Email
Print
Heparin Sodium Market Overview
Heparin Sodium Market size is estimated to reach $2.4 billion by 2027, growing at a CAGR of 3.6% during the forecast period 2022-2027. On bifurcating the word Heparin, we get Hepa and rin. Hepa means liver and rin means GAGs (= “Glycosaminoglycans”, compounds formed following the composition of disaccharide units. GAGs are expedient in preclusion of blood clots). Therefore, Heparin Sodium can be demarcated as an anticoagulant that discourages agglomeration of the blood in angio/arteries, phlebo/veins, heart. Heparins are derived from porcine intestinal tissue and are largely used in treatments accompanied with DIC (= Disseminated Intravascular Coagulation, a sickness embarking on the genesis of thickets of condensed blood in vessels carrying it and suspending the stream of plasma/blood to principal parts of the body such as cerebrum, excretory organs, and liver. Ascension in stalwart efforts of researchers in the field of nanotechnology, massive capita financing by the government to research, and academic institution to carry forward their work are the few factors set to drive the growth of the Heparin Sodium Industry for the period 2022-2027.
Report Coverage:
The report: “Heparin Sodium Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Heparin Sodium Market.
By Administration: Oral and Interposable/Injectable.
By Product Type: High Molecular Weight Heparins, LMWH 4.5 kDa, Heparinoids, Chondroitin sulfate, Unfractionated Heparins.
By Ailment curation: Cardiovascular Diseases, Pregnancy Hitches, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).
Key Takeaways:
- Geographically, the North America Heparin Sodium Market accounted for the highest revenue share in 2021. However, the Asia-Pacific is poised to dominate the market over the period 2022-2027 owing to the intensification in population and improving healthcare infrastructure.
- The swelling in ailments such as thrombosis that engender blood clotting complications is driving the Heparin Sodium Market. However, side effects posed by heparins like excessive bleeding are one of the major factors that are said to reduce the growth of the Heparin Sodium Market.
- Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Heparin Sodium Market report.
Heparin Sodium Market- Geography (%) for 2021.
For more details on this report - Request for Sample
Heparin Sodium Market Segment Analysis-By Administration Type
The Heparin Sodium Market based on the Storage Type can be further segmented into Oral, Interposable/Injectable. The Injectable heparin segment held the largest share owing to the factors such as the rife presence of heparins in fluid form as compared to physical pills. Heparins are not swallowed orally accrediting to their dimensions/size.
Therefore, the injectable segment is appraised to be the fastest-growing segment with a CAGR of 4.1% over the period 2022-2027. This growth is owing to higher efficacy of respective mode due to easier and quick absorption in skin, contraction in an overall period of the therapy, majority of the heparins used are of LMW (=lower molecular weight) and LMW heparins contemplated as futile if taken orally which is why maximum time they are administered through injectable routes. On top of that, progression, and breakthroughs like needle-free injectors in the subcutaneous market are fueling the progress of this certain segment.
Heparin Sodium Market Segment Analysis-By Ailment Curation Type
The Heparin Sodium Market based on the Ailment Curation can be further segmented into cardiovascular diseases (=Disseminated Intravascular Coagulation, Atrial fibrillation, VTE many more), Pregnancy Hitches, and many more. The Cardiovascular segment held the largest share in 2021 owing to the factors such as an Increase in maladies such as DVT, PAD (=peripheral artery disease), antiphospholipid syndrome, increasing trend of smoking, obesity problems, swell in accident cases leading to serious injuries. Moreover, obesity problems have been growing severe day-day, as in 1999-2000, the prevalence was close to 30.5%, and the prevalence has increased to 42.4% in 2018-19.
Similarly, the Cardiac maladies segment is estimated to be the fastest-growing segment with a CAGR of 4.2% over the forecast period 2022-2027. This growth is owing to increasing incidences of thrombosis stimulating clotting in plasma, an increasing number of prominent market players in the medical field, massive flows of an innumerable amount of hard cash into research and development leading to numerous jaw-dropping breakthroughs and unearthing of new drugs.
Heparin Sodium Market Segment Analysis-By Geography
The Heparin Sodium based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 35% of the overall market in 2021. The growth in this segment is owing to the factors such as mounting injuries due to prevalent sports culture, utter intensification in cardiovascular maladies, budding old age population, the existence of high responsiveness among people, world-class health infrastructure facilities such as laboratories, diagnostic techniques, well-equipped hospitals.
However, the Asia-pacific segment is estimated to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to outpouring demand for amended healthcare set-up as the population in India and China is swelling exceptionally, innumerable movements of riches into research and development as economies of many Asian nations are flourishing. Interestingly, India saw an incremental budget for healthcare, which saw a YoY rise by 137% from 2020.
Heparin Sodium Market Drivers
Technological breakthroughs Projected to Drive Market Growth.
Several technological breakthroughs in the heparin market such as oral cavity delivery system, development of fresh oral agents through blending of deoxycholic acid with LMWH along with various other medical contemporary techniques such as various imaging, advancing hypodermics techniques providing an inclusive and preeminent means to unravel the health snags of contemporary society. These techniques function with jaw-dropping precision and diagnose infinitesimal problems from the patient’s body all these factors are boosting the progress of the Heparin sodium Market.
Escalation in blood anomalies is Expected to Boost Product Demand.
Cases of thrombosis are on the upsurge and leading to a colossal surge in complications related to blood such as blockade and seepage in blood vessels that source blood to numerous parts of the body after going through the processes of oxygenation and reoxygenation. The prevalence of venous thrombosis is close to 1-2 per 1,000 each year within the state of the US. Growing smoking trends among teenagers as well as adults, obesity complications due to poor ingesting habits are adding insult to injury. Fading immunity ensures an expansion in blood idiosyncrasies such as blood cancer, seepage of blood, and blood clotting.
Heparin Sodium Market Challenges
Side effects of heparins And Hampered supply chain is Anticipated to Hamper Market Growth.
Heparins are generally used as anticoagulants. But in a few cases, they result in disproportionate bleeding and pose several side effects in patients’ bodies such as tenderness hitches, redness, and vicissitudes in areas where heparins are administered through injectors. On top of that due to lockdowns, and trade restrictions following the COVID-19 the supply chain of indispensable raw materials such as APIs (= active pharmaceutical ingredients), additives for engineering medicines have been curbed. These factors can turn out as an obstruction to the growth of the Heparin sodium market. Moreover, a direct correlation has been established with the emergence of a new variant of Sars-Cov-19 and supply chain hampering.
Heparin Sodium Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in this market. Heparin Sodium top 10 companies include:
- SPL
- Nanjing King-Friend
- Opocrin
- Biometrical
- Xinbai Pharmaceuticals
- Pharma Action
- Shenzhen Hepalink
- Baxter
- Pfizer
- Aspen Oss
Recent Developments/Product Launches:
- In November 2021, US food and drug regulator said that the regulatory body is planning to give approval to Pfizer’s COVID-19 booster shots that are called as Pfizer-BioNTech. CDC and PIC organized a conference to mull upon the safety of the booster shots. Additionally, the US-based leading pharmaceutical and vaccine manufacturing company Pfizer publicized that company has signed an agreement to vend a total of 10 million PAXLOVID pills to the US government. The deal is finalized for $5.29 billion.
- In November 2021, Austrian researchers at “University of Vienna” claimed that broadly used anticoagulant heparin is Researchers have now shown that a member of the anticoagulant group of drugs not only has a beneficial effect on the survival of COVID-19 patients but also influences the duration of active infection with the SARS-CoV-2 coronavirus. Three hospitals were involved in the study; Favoriten Hospital; Innsbruck Hospital, and Johannes Kepler University.
- In September 2019, Meitheal Pharmaceuticals announced the launch of the company’s eight presentations of heparin sodium injections, USP, and United States. Meitheal primarily specializes in the development, manufacture, procurement, and sale of generic injectable pharmaceuticals, with 12 FDA-approved products covering indications for anti-infective, oncolytic, and intensive care.
Relevant Links:
Report Code: HCR 33200
1. Heparin Sodium Market Overview
1.1 Definitions and Scope
2. Heparin Sodium Market - Executive Summary
3. Heparin Sodium Market – Market Landscape
3.1 Company Benchmarking- Key Companies
3.2 Key Company Financial Analysis
3.3 Market Share Analysis
3.4 Patent Analysis
3.5 Pricing Analysis (Comparison of General Price Offerings in the Market)
4. Heparin Sodium Market – Startup Company Scenario (Premium)
4.1 Investment
4.2 Revenue
4.3 Venture Capital and Funding Scenario
5. Heparin Sodium Market – Industry Market Entry Scenario Premium (Premium)
5.1 Regulatory Scenario
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Heparin Sodium Market - Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porters five force model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Heparin Sodium Market – By Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle Analysis
8. Heparin Sodium Market - By Administration Type (Market Size –$Million/$Billion)
8.1 Oral
8.2 Interposable/Injectable
9. Heparin Sodium Market - By Product Type (Market Size –$Million/$Billion)
9.1 High molecular weight heparins (= 15 kDa)
9.2 LMWH 4.5 kDa (= dalteparin, tinzaparin, enoxaparin)
9.3 Heparinoids (Dermatan sulfate, Chondroitin sulfate, keratan sulfate)
9.4 Unfractionated heparins
10. Heparin Sodium Market – By Ailment Curation Type (Market Size –$Million/$Billion)
10.1 Cardiovascular diseases
10.2 Pregnancy hitches
11. Heparin Sodium Market - By Geography (Market Size -$Million/Billion)
11.1 North America
11.1.1 U.S
11.1.2 Canada
11.1.3 Mexico
11.2 Europe
11.2.1 Germany
11.2.2 France
11.2.3 UK
11.2.4 Italy
11.2.5 Spain
11.2.6 Russia
11.2.7 Rest of Europe
11.3 Asia-Pacific
11.3.1 China
11.3.2 Japan
11.3.3 South Korea
11.3.4 India
11.3.5 Australia & New Zealand
11.3.6 Rest of Asia-Pacific
11.4 South America
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Chile
11.4.4 Colombia
11.4.5 Rest of South America
11.5 Rest Of The World
11.5.1 Middle East
11.5.2 Africa
12. Heparin Sodium Market - Market Entropy
12.1 New product launches
12.2 M&A's, collaborations, JVs, and partnerships
13. Heparin Sodium Market – Industry Competition Landscape (Premium)
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key Companies
13.1.3 Market Share by Countries – Key Companies
13.2 Competition Matrix
13.3 Best Practices for Companies
14. Heparin Sodium Market – Key Company List by Country Premium (Premium)
15. Heparin Sodium Market - Company Analysis
15.1 Company 1
15.2 Company 2
15.3 Company 3
15.4 Company 4
15.5 Company 5
15.6 Company 6
15.7 Company 7
15.8 Company 8
15.9 Company 9
15.10 Company 10
"*Financials would be provided on a best-efforts basis for private companies"
LIST OF TABLES
1.Global Heparin Sodium Market, By Type Market 2023-2030 ($M)1.1 Unfractionated Heparin Market 2023-2030 ($M) - Global Industry Research
1.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Global Industry Research
1.3 Heparinoids Market 2023-2030 ($M) - Global Industry Research
2.Global Heparin Sodium Market, By Type Market 2023-2030 (Volume/Units)
2.1 Unfractionated Heparin Market 2023-2030 (Volume/Units) - Global Industry Research
2.2 Low Molecular Weight Heparin Market 2023-2030 (Volume/Units) - Global Industry Research
2.3 Heparinoids Market 2023-2030 (Volume/Units) - Global Industry Research
3.North America Heparin Sodium Market, By Type Market 2023-2030 ($M)
3.1 Unfractionated Heparin Market 2023-2030 ($M) - Regional Industry Research
3.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Regional Industry Research
3.3 Heparinoids Market 2023-2030 ($M) - Regional Industry Research
4.South America Heparin Sodium Market, By Type Market 2023-2030 ($M)
4.1 Unfractionated Heparin Market 2023-2030 ($M) - Regional Industry Research
4.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Regional Industry Research
4.3 Heparinoids Market 2023-2030 ($M) - Regional Industry Research
5.Europe Heparin Sodium Market, By Type Market 2023-2030 ($M)
5.1 Unfractionated Heparin Market 2023-2030 ($M) - Regional Industry Research
5.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Regional Industry Research
5.3 Heparinoids Market 2023-2030 ($M) - Regional Industry Research
6.APAC Heparin Sodium Market, By Type Market 2023-2030 ($M)
6.1 Unfractionated Heparin Market 2023-2030 ($M) - Regional Industry Research
6.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Regional Industry Research
6.3 Heparinoids Market 2023-2030 ($M) - Regional Industry Research
7.MENA Heparin Sodium Market, By Type Market 2023-2030 ($M)
7.1 Unfractionated Heparin Market 2023-2030 ($M) - Regional Industry Research
7.2 Low Molecular Weight Heparin Market 2023-2030 ($M) - Regional Industry Research
7.3 Heparinoids Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Heparin Sodium Market Revenue, 2023-2030 ($M)2.Canada Heparin Sodium Market Revenue, 2023-2030 ($M)
3.Mexico Heparin Sodium Market Revenue, 2023-2030 ($M)
4.Brazil Heparin Sodium Market Revenue, 2023-2030 ($M)
5.Argentina Heparin Sodium Market Revenue, 2023-2030 ($M)
6.Peru Heparin Sodium Market Revenue, 2023-2030 ($M)
7.Colombia Heparin Sodium Market Revenue, 2023-2030 ($M)
8.Chile Heparin Sodium Market Revenue, 2023-2030 ($M)
9.Rest of South America Heparin Sodium Market Revenue, 2023-2030 ($M)
10.UK Heparin Sodium Market Revenue, 2023-2030 ($M)
11.Germany Heparin Sodium Market Revenue, 2023-2030 ($M)
12.France Heparin Sodium Market Revenue, 2023-2030 ($M)
13.Italy Heparin Sodium Market Revenue, 2023-2030 ($M)
14.Spain Heparin Sodium Market Revenue, 2023-2030 ($M)
15.Rest of Europe Heparin Sodium Market Revenue, 2023-2030 ($M)
16.China Heparin Sodium Market Revenue, 2023-2030 ($M)
17.India Heparin Sodium Market Revenue, 2023-2030 ($M)
18.Japan Heparin Sodium Market Revenue, 2023-2030 ($M)
19.South Korea Heparin Sodium Market Revenue, 2023-2030 ($M)
20.South Africa Heparin Sodium Market Revenue, 2023-2030 ($M)
21.North America Heparin Sodium By Application
22.South America Heparin Sodium By Application
23.Europe Heparin Sodium By Application
24.APAC Heparin Sodium By Application
25.MENA Heparin Sodium By Application
26.Shenzhen Hepalink, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Ichuan Deebio Pharmaceutical Co Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Nanjing Xinbai Pharmaceutical Co , Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Hebei Changshan Biochemical Pharmaceutical Co., Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Yantai Dongcheng Biochemicals Co Ltd, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Pharma Action Gmbh, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Opocrin S.P.A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Bioibrica, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Aspen Os Bv, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)